Blog

The Market Changes Daily

We help you stay one step ahead.

Report on Drugs with Unsupported Price Increases

Report on Drugs with Unsupported Price Increases

Founded in 2006, the Institute for Clinical and Economic Review (ICER) is an independent and non-partisan research organization that objectively evaluates the clinical and economic value of prescription drugs, medical tests, and other health care and health care delivery innovations.

read more
Don’t Be Afraid of Your PBM

Don’t Be Afraid of Your PBM

What if we told you that formulary and PBM management can help you stop SAVE money and STOP overspending before it hits your bottom line? Now, what if we told you that those savings could dwarf your cherished PBM rebates?

read more
Generic Prozac: Capsules or Tablets?

Generic Prozac: Capsules or Tablets?

Prozac (fluoxetine) a safe, effective drug that has given millions of patients relief from symptoms of major depression, obsessive-compulsive disorder, panic disorder, and other debilitating conditions. But why are the tablets more expensive than the capsules?

read more
Drug Coupons Have Everyone Bamboozled

Drug Coupons Have Everyone Bamboozled

The government issued a confusing new rule designed to curb the use of drug manufacturer coupons, then delayed its implementation until 2021. We feel their pain. Drug coupons are everywhere. You’ll find them in the mail, online, and in most magazines. Many patients,...

read more
“Talk to Your Doctor” and Save?

“Talk to Your Doctor” and Save?

You’ve seen the television commercials and glossy magazine ads, recommending a conversation with “your own trusted doctor.” Seems like good advice. But by controlling that conversation – right there in the examining room – Big Pharma is able to sell us drugs we don’t need at prices we can’t afford.

read more
Authorized Generics Explained

Authorized Generics Explained

Designed to stifle competition and circumvent rebate deals with Pharmacy Benefit Managers, authorized generics are one of the most profitable market sectors for drug makers, returning $50 for every $1 invested.

read more
A Brave (Expensive) New World for Payers

A Brave (Expensive) New World for Payers

The questions of how expensive gene therapies are going to be covered, who will be paying for them, and how our healthcare system can adapt to support getting these cures to those who desperately need them – are not easy questions – but everyone, including the drug companies, are asking them.

read more
The Latest on Drug Patent Scams

The Latest on Drug Patent Scams

The U.S. patent system not only allows but also incentivizes anti-competitive practices, driving up costs for everybody—patients, government payers, and insurers—while at the same time stifling the innovation that high drug prices are supposed to fund.

read more
Generic Drugmakers Are in Big Trouble

Generic Drugmakers Are in Big Trouble

A major lawsuit accuses generic drug makers of a price-fixing conspiracy and “billions of dollars of damage” to the US economy… Proof once again that generics now require as much (if not more) vigilance from payers as do brand-name drugs.

read more
About the CVS E-Prescription Initiative

About the CVS E-Prescription Initiative

Don’t forget that pricing varies from pharmacy to pharmacy—sometimes dramatically. Scripta ensures that patients know where to shop for the best price for a given medication, even if that is at Walmart or other CVS competitors.

read more